Aquestive Therapeutics (AQST) Treasury Shares (2018 - 2026)

Aquestive Therapeutics' Treasury Shares history runs 9 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 14.0% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (down 14.0% YoY), while the FY2025 annual figure was $1.7 million, up 59.7% from the prior year.
• Treasury Shares was $2.8 million for Q1 2026 at Aquestive Therapeutics, up from $1.7 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.3 million in Q1 2025 to a low of $162000.0 in Q4 2022.
• Historically, Treasury Shares has averaged $1.7 million across 5 years, with a median of $1.8 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 2025.0% in 2022, then sank 32.22% in 2025.
• A 5-year view of Treasury Shares shows it stood at $162000.0 in 2022, then soared by 722.22% to $1.3 million in 2023, then decreased by 18.77% to $1.1 million in 2024, then surged by 59.7% to $1.7 million in 2025, then soared by 64.29% to $2.8 million in 2026.
• The last three Treasury Shares figures came in at $2.8 million (Q1 2026), $1.7 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.